GSK-2018682
Maka nyocha sayensị naanị, ọ bụghị maka ndị ọrịa.
Nkọwa ngwaahịa
Mkpado ngwaahịa
| Nha ngwugwu | Nnweta | Ọnụ ego (USD) |
Aha kemịkalụ:
4- (4- (5- (5-chloro-6-isopropoxypyridin-3-yl) -1,2,4-oxadiazol-3-yl) -1H-indol-1-yl) butanoic acid.
Koodu Ọchịchọ:
O=C(O)CCCN1C=CC2=C1C=CC=C2C3=NOC(C4=CC(Cl)=C(OC(C)C)N=C4)=N3
Koodu InChi:
InChi=1S/C22H21ClN4O4/c1-13(2)30-22-17(23)11-14(12-24-22)21-25-20(26-31-21)16-5 -3-6-18-15(16)8-10-27(18)9-4-7-19(28)29/h3,5-6,8,10-13H,4,7,9H2,1 -2H3, (H,28,29)
Igodo InChi:
NFIGDBFIDKDNIG-UHFFFAOYSA-N
Okwu:
1034688-30-6;CAS:1034688-30-6;CAS:1034688-30-6;GSK-2018682;GSK 2018682；GSK2018682; 2018682
Solubility:Soluble na DMSO
Nchekwa:0 - 4 C maka obere oge (ụbọchị ruo izu), ma ọ bụ -20 C maka ogologo oge (ọnwa).
Nkọwa:
GSK2018682 bụ agonist maka ndị na-anabata S1P1 na S1P5.
Ebumnuche: Agonists maka ndị nnata S1P1 na S1P5
![(S) -2- (4- (4- (4- (5- (1-amino-1---4-fluorophenyl) ethyl) pyrimidin-2-yl) piperazin-1-yl) pyrrolo [2,1-] f [1,2,4]triazin-6-yl)-1H-pyrazol-1-yl)ethan-1-ol](http://www.caerulumpharm.com/uploads/微信截图_20220802163212-300x280.png)
